Coegin Pharma har en solid IP-portfölj med 20 patentfamiljer inkluderande substanspatent, användarpatent, kombinationspatent och formuleringspatent. Patentfamiljerna i tabellen nedan har lämnats in i USA, Europa, Kanada, Japan, Australien och även i andra områden som Kina, Hongkong, Korea, Indien, Israel, Nya Zeeland och Norge. Patentfamiljerna är giltiga från och med 2023 till och med 2037.
|
Utvalda patentfamiljer |
Beviljade |
Pending |
|
|
PCT/GB03/000364 |
AVX001 type ketones for the treatment of psoriasis AVX001 type ketones in a pharmaceutical composition |
Multiple granted United States patents |
|
|
PCT/2010/064687 |
Oxothiazole compounds and their use for the treatment of certain chronic inflammatory conditions |
Europe, United States, United States Continuation, Australia, Australia (divisional), Canada, China, China (Divisional), Japan, Republic of Korea, Republic of Korea (divisional), Hong Kong |
|
|
PCT/EP2010/003384 |
AVX001 type ketones for the treatment of glomerulonephritis |
Europe, Europe (Divisional), United States, Australia, Canada, Japan |
|
|
PCT/EP2014/051655 |
Oxothiazole compounds and their use in the treatment of chronic inflammatory disorders and proliferative disorders such as cancer |
Europe, United States, Australia, China, India, Japan |
Republic of Korea, Canada, China (divisional) |
|
PCT/EP2015/067836 |
Oxothiazole compounds and their use for the treatment of chronic inflammatory disorders and proliferative disorders such as cancer |
Europe, United States, Australia, Japan |
Canada, China, India, Republic of Korea, Hong Kong, United States (continuation) |
|
PCT/EP2015/061534 |
AVX001 type ketones for the treatment of skin cancer |
Europe, United States, Australia |
Canada, China, Republic of Korea |
|
PCT/EP2017/056022 |
AVX001 and AVX002 in combination with BEZ235 |
Australia |
Europe, United States, Canada, China, Japan, Republic of Korea, New Zealand, Hong Kong |
|
PCT/EP2017/056016 |
AVX235 and AVX420 in combination with BEZ235 |
Australia |
Europe, United States, Canada, China, Japan, New Zealand, Republic of Korea, Hong Kong |
|
PCT/EP2017/073951 |
Formulation comprising AVX001 type ketones and silicone |
Australia |
Europe, United States, Canada, China, India, Israel, Japan, New Zealand, Republic of Korea |
|
PCT/EP2017/078169 |
Oxothiazole compounds in combination with a secosteroid |
Australia |
Europe, United States, China, Israel, New Zealand |
|
PCT/EP2017/078162 |
Oxothiazole compounds in combination with a corticosteroid |
Australia |
Europe, United States, Canada, China, Israel, New Zealand |
|
PCT/EP2018/066028 |
AVX001 type ketones for the treatment of fibrotic diseases |
|
Europe, United States, Australia, Canada, China, Japan |
|
PCT/EP2019/060544 |
Oxothiazole compounds for the treatment of fibrotic diseases |
|
United States, China, Japan, Europe |